InvestorsObserver
×
News Home

Is Ocuphire Pharma Inc (OCUP) a Winner in the Healthcare Sector?

Tuesday, September 26, 2023 01:32 PM | InvestorsObserver Analysts

Mentioned in this article

Is Ocuphire Pharma Inc (OCUP) a Winner in the Healthcare Sector?

A rating of 74 puts Ocuphire Pharma Inc (OCUP) near the top of the Healthcare sector according to InvestorsObserver. Ocuphire Pharma Inc's score of 74 means that it ranks higher than 74% of stocks in the sector. In addition, its overall score of 39 ranks it higher than 39% of all stocks.

Overall Score - 39
OCUP has an Overall Score of 39. Find out what this means to you and get the rest of the rankings on OCUP!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 39 would rank higher than 39 percent of all stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Ocuphire Pharma Inc Stock Today?

Ocuphire Pharma Inc (OCUP) stock has gained 8.46% while the S&P 500 has fallen -1.19% as of 1:16 PM on Tuesday, Sep 26. OCUP has risen $0.33 from the previous closing price of $3.90 on volume of 642,846 shares. Over the past year the S&P 500 is higher by 17.26% while OCUP has risen 113.64%. OCUP earned $0.71 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 5.99. Click Here to get the full Stock Report for Ocuphire Pharma Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App